Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Grottoli

Showing results (41-50 of 124) with videos related to

Pageof 13
Sort By:
Journal of Endocrinological Investigation|June 20, 1998
Effects of 3-month nifedipine treatment on endocrine-metabolic parameters in patients with abdominal obesity and mild hypertensionM Maccario, S E Oleandri, E Avogadri, et al.
European Journal of Endocrinology|August 1, 1996
Effects of glucose load and/or arginine on insulin and growth hormone secretion in hyperprolactinemia and obesityM Maccario, S Grottoli, P Razzore, et al.
Journal of Endocrinological Investigation|June 24, 2022
Mean GH profile is more accurate than single fasting GH in the evaluation of acromegaly disease control during somatostatin receptor ligands therapyC Bona, N Prencipe, A M Berton, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|September 21, 2000
Alprazolam, a benzodiazepine, blunts but does not abolish the ACTH and cortisol response to hexarelin, a GHRP, in obese patientsS Grottoli, E Arvat, C Gauna, et al.
Metabolism: Clinical and Experimental|March 1, 1996
Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesityM Maccario, M Procopio, S Grottoli, et al.
Journal of Endocrinological Investigation|December 31, 1997
Long-term treatment with cabergoline, a new long-lasting ergoline derivate, in idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced pregnancyE Ciccarelli, S Grottoli, P Razzore, et al.
Journal of Endocrinological Investigation|January 1, 1997
Effects of cholinergic blockade by pirenzepine on insulin and glucose response to oral and intravenous glucose and to arginine load in obesityM Maccario, S Grottoli, M Procopio, et al.
Journal of Endocrinological Investigation|February 28, 2009
Growth hormone/insulin-like growth factor I axis, glucose metabolism, and lypolisis but not leptin show some degree of refractoriness to short-term fasting in acromegalyS Grottoli, V Gasco, A Mainolfi, et al.
European Journal of Endocrinology|September 23, 2008
Retesting the childhood-onset GH-deficient patientV Gasco, G Corneli, G Beccuti, et al.
European Journal of Endocrinology|September 26, 2007
The activation of somatostatinergic receptors by either somatostatin-14 or cortistatin-17 often inhibits ACTH hypersecretion in patients with Cushing's diseaseR Giordano, A Picu, L Bonelli, et al.
Pageof 13

Showing results (41-50 of 124) with videos related to

Sort By:
Pageof 13
Journal of Endocrinological Investigation|June 20, 1998
Effects of 3-month nifedipine treatment on endocrine-metabolic parameters in patients with abdominal obesity and mild hypertensionM Maccario, S E Oleandri, E Avogadri, et al.
European Journal of Endocrinology|August 1, 1996
Effects of glucose load and/or arginine on insulin and growth hormone secretion in hyperprolactinemia and obesityM Maccario, S Grottoli, P Razzore, et al.
Journal of Endocrinological Investigation|June 24, 2022
Mean GH profile is more accurate than single fasting GH in the evaluation of acromegaly disease control during somatostatin receptor ligands therapyC Bona, N Prencipe, A M Berton, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|September 21, 2000
Alprazolam, a benzodiazepine, blunts but does not abolish the ACTH and cortisol response to hexarelin, a GHRP, in obese patientsS Grottoli, E Arvat, C Gauna, et al.
Metabolism: Clinical and Experimental|March 1, 1996
Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesityM Maccario, M Procopio, S Grottoli, et al.
Journal of Endocrinological Investigation|December 31, 1997
Long-term treatment with cabergoline, a new long-lasting ergoline derivate, in idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced pregnancyE Ciccarelli, S Grottoli, P Razzore, et al.
Journal of Endocrinological Investigation|January 1, 1997
Effects of cholinergic blockade by pirenzepine on insulin and glucose response to oral and intravenous glucose and to arginine load in obesityM Maccario, S Grottoli, M Procopio, et al.
Journal of Endocrinological Investigation|February 28, 2009
Growth hormone/insulin-like growth factor I axis, glucose metabolism, and lypolisis but not leptin show some degree of refractoriness to short-term fasting in acromegalyS Grottoli, V Gasco, A Mainolfi, et al.
European Journal of Endocrinology|September 23, 2008
Retesting the childhood-onset GH-deficient patientV Gasco, G Corneli, G Beccuti, et al.
European Journal of Endocrinology|September 26, 2007
The activation of somatostatinergic receptors by either somatostatin-14 or cortistatin-17 often inhibits ACTH hypersecretion in patients with Cushing's diseaseR Giordano, A Picu, L Bonelli, et al.
Pageof 13